AngioDynamics | ANGO - Selling And Administration Expenses


AngioDynamics reported $36.57M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Artivion USD 55.75M 4.54M Dec/2025
AtriCure USD 82.56M 1.99M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
ICU Medical USD 151.92M 2.64M Jun/2026
Inogen USD 43.77M 510K Jun/2024
J&J USD 6.25B 168M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
Orthofix International USD 130.35M 11.31M Dec/2025
Smiths GBP 80M 1000K Dec/2026
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
Terumo JPY 109.7B 5.11B Jun/2026
Trinity Biotech USD 5.78M 405K Dec/2025